Our newest list of the best stocks to buy all hail from the tech sector.
One company makes pharmaceutical products for the treatment of renal disease. Its stock has enjoyed a 780% run over the last two years, but it recently dipped due to a false media report. Investors can nab shares now at a deep discount.
Our defense & tech specialist highlighted an ETF play that takes advantage of recent CEO changes in some of the top tech companies, plus two big-cap tech stocks with promising technical charts.